Harris Benjamin S, Acharya Kelly S, Unnithan Shakthi, Neal Shelby A, Mebane Sloane, Truong Tracy, Muasher Suheil J
Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology and Infertility, Duke University Health System, Morrisville, North Carolina; Department of Obstetrics and Gynecology, Shady Grove Fertility - Jones Institute, Eastern Virginia Medical School, Norfolk, Virginia.
Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology and Infertility, Duke University Health System, Morrisville, North Carolina.
Fertil Steril. 2025 Mar;123(3):428-438. doi: 10.1016/j.fertnstert.2024.09.043. Epub 2024 Sep 29.
To evaluate cumulative live birth after preimplantation genetic testing for aneuploidy (PGT-A) with next generation sequencing (NGS) compared with morphology alone among patients aged 21-40 years undergoing single blastocyst transfer.
Retrospective cohort study.
Patients aged 21-40 years undergoing first autologous retrieval cycles resulting in ≥5 fertilized oocytes, with subsequent single blastocyst transfer in Society for Assisted Reproductive Technology clinics from 2016-2019.
PGT-A using NGS.
The primary outcome was cumulative live birth per retrieval. Secondary outcomes included clinical pregnancy, miscarriage, and live birth per transfer.
A total of 56,469 retrieval cycles were included in the analysis. Retrieval cycles were stratified based on age (<35, 35-37, and 38-40 years) and exposure to PGT-A with NGS. Modified Poisson regression modeling was used to evaluate the association between PGT-A and cumulative live birth per retrieval while controlling for covariates. In this cohort, most cycles did not use PGT-A (n = 49,608; 88%). After adjusting for covariates, the use of PGT-A was associated with a slightly lower cumulative live birth in individuals aged <35 years (risk ratio [RR]: 0.96; 95% CI: 0.93-0.99) compared with no PGT, but higher cumulative live birth in ages 35-37 years (RR: 1.04; 95% CI: 1.00-1.08), and 38-40 years (RR: 1.14; 95% CI: 1.07-1.20). A subgroup analysis limited to freeze-all cycles (n = 29,041) showed that PGT-A was associated with higher cumulative live birth in individuals aged ≥35 years and was similar to no PGT in individuals aged <35 years. Miscarriage was significantly less likely in individuals aged ≥35 years using PGT-A compared with no PGT-A.
In this large national database study, success rates in cycles using PGT-A were dependent on age. Cumulative live birth was observed to be significantly less likely in PGT-A cycles among individuals aged <35 years and more likely among individuals aged 38-40 years, compared with no PGT-A. In individuals with no fresh transfer, results were similar. Moreover, miscarriage was significantly less likely with PGT-A among individuals aged 35-40 years in a subgroup analysis of freeze-all cycles.
评估在接受单囊胚移植的21至40岁患者中,与单纯形态学评估相比,采用下一代测序(NGS)进行非整倍体植入前基因检测(PGT-A)后的累积活产情况。
回顾性队列研究。
年龄在21至40岁之间,进行首次自体取卵周期且产生≥5个受精卵,随后于2016年至2019年在辅助生殖技术协会诊所进行单囊胚移植的患者。
使用NGS进行PGT-A。
主要结局为每次取卵后的累积活产。次要结局包括临床妊娠、流产以及每次移植后的活产。
分析共纳入56469个取卵周期。取卵周期根据年龄(<35岁、35至37岁和38至40岁)以及是否接受使用NGS的PGT-A进行分层。采用修正泊松回归模型评估PGT-A与每次取卵后的累积活产之间的关联,同时控制协变量。在该队列中,大多数周期未使用PGT-A(n = 49608;88%)。调整协变量后,与未使用PGT-A相比,<35岁的个体使用PGT-A后的累积活产略低(风险比[RR]:0.96;95%置信区间[CI]:0.93 - 0.99),但35至37岁(RR:1.04;95% CI:1.00 - 1.08)和38至40岁(RR:1.14;95% CI:1.07 - 1.20)的个体累积活产较高。一项仅限于全冷冻周期(n = 29041)的亚组分析显示,PGT-A与≥35岁个体的较高累积活产相关,而与<35岁个体未使用PGT-A时的情况相似。与未使用PGT-A相比,≥35岁使用PGT-A的个体流产可能性显著降低。
在这项大型全国性数据库研究中,使用PGT-A的周期成功率取决于年龄。与未使用PGT-A相比,<35岁个体的PGT-A周期中累积活产显著降低,而38至40岁个体的累积活产更有可能。在没有新鲜移植的个体中,结果相似。此外,在全冷冻周期的亚组分析中,35至40岁个体使用PGT-A时流产可能性显著降低。